# Trade Mark Journal No.2026/008 20 February 2026

## WO0000001866762 (42)

Office of origin: Australia

Date of International Registration:26 June 2025
Date of designation in the UK: 22 December 2025

International priority date claimed: 26 June 2025 (Australia) (2561018)

Class 42
  Scientific research; clinical trials; clinical research; testing of pharmaceuticals; laboratory testing; medical research; pharmaceutical research consultancy; research and development in the field of pharmaceuticals.

Telix Pharmaceuticals Limited

Representative: Herbert Smith Freehills Kramer, Level 24, 80 Collins Street, Melbourne VIC 3000, AUSTRALIA